Global Health Recommends Final Dividend of ₹0.50 Per Share

Global Health Limited's Board of Directors, in a meeting held on May 14, 2026, approved the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The board recommended a final dividend of ₹0.50 (25%) per equity share of face value ₹2 each, subject to shareholder approval at the upcoming AGM. The record date for dividend eligibility will be announced separately. Additionally, Mr. Kedar Ashok Apte and Mr. Jagdeep Singh were appointed as Chief Marketing & Growth Officer and General Counsel, respectively, effective May 14, 2026. The resignation of Ms. Richa Singh as SMP was noted, effective May 20, 2026.